Mississauga, Canada

Sana Rasheed

This inventor holds 1 USPTO granted patent. Top assignees: 2692372 Ontario, Inc., Dunad Therapeutics Ltd.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sana Rasheed

Introduction

Sana Rasheed is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzenesulfonamide derivatives. His research focuses on the disruption of proteins and polypeptides, which has implications for treating various diseases.

Latest Patents

Sana Rasheed holds a patent for "Benzenesulfonamide derivatives and uses thereof." This patent includes compounds that have the potential to disrupt protein and polypeptide functions, which can be crucial in addressing diseases linked to these biological molecules. The compounds feature fluorinated benzene sulfonamide structures, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Sana has worked with several companies, including Dunad Therapeutics Ltd. and 2692372 Ontario, Inc. His experience in these organizations has allowed him to apply his research in practical settings, contributing to advancements in therapeutic solutions.

Collaborations

Sana Rasheed has collaborated with notable professionals in his field, including Patrick T. Gunning and Olga Gozhina. These partnerships have enriched his research and expanded the impact of his work in the pharmaceutical industry.

Conclusion

Sana Rasheed's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…